AIP
CGEM icon

Ameritas Investment Partners’s Cullinan Oncology CGEM Stock Holding History

Ameritas Investment Partners’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.2K Hold
4,305
– – ﹤0.01% 1974
2025
Q4 		$44.6K Sell
4,305
-935
-18% -$8.43K ﹤0.01% 2208
2025
Q3 		$31.1K Hold
5,240
– – ﹤0.01% 2462
2025
Q2 		$39.5K Hold
5,240
– – ﹤0.01% 2338
2025
Q1 		$39.7K Hold
5,240
– – ﹤0.01% 2242
2024
Q4 		$63.8K Hold
5,240
– – ﹤0.01% 2039
2024
Q3 		$87.7K Buy
5,240
+1,453
+38% +$25.8K ﹤0.01% 1876
2024
Q2 		$66K Buy
3,787
+1,188
+46% +$25.3K ﹤0.01% 1982
2024
Q1 		$44.3K Buy
2,599
+615
+31% +$9.5K ﹤0.01% 2221
2023
Q4 		$20.2K Hold
1,984
– – ﹤0.01% 2579
2023
Q3 		$18K Hold
1,984
– – ﹤0.01% 2594
2023
Q2 		$21.3K Hold
1,984
– – ﹤0.01% 2530
2023
Q1 		$20.3K Hold
1,984
– – ﹤0.01% 2461
2022
Q4 		$20.8K Hold
1,984
– – ﹤0.01% 2548
2022
Q3 		$25K Hold
1,984
– – ﹤0.01% 2403
2022
Q2 		$25K Hold
1,984
– – ﹤0.01% 2430
2022
Q1 		$21K Hold
1,984
– – ﹤0.01% 2535
2021
Q4 		$31K Hold
1,984
– – ﹤0.01% 2417
2021
Q3 		$45K Buy
1,984
+916
+86% +$24.5K ﹤0.01% 2231
2021
Q2 		$28K Hold
1,068
– – ﹤0.01% 2542
2021
Q1 		$45K Buy
+1,068
New +$43.4K ﹤0.01% 2139

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Ameritas Investment Partners's CGEM Position: Q1 2026 in Review

Ameritas Investment Partners held its Cullinan Oncology (CGEM) position steady in Q1 2026 at 4,305 shares worth $61.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

Ameritas Investment Partners first reported a position in CGEM in Q1 2021 and has held it in 21 quarters since. The position peaked at $87.7K in Q3 2024. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Ameritas Investment Partners held 4,305 shares of Cullinan Oncology worth $61.2K as of Q1 2026.
  • Ameritas Investment Partners left its Cullinan Oncology share count unchanged in Q1 2026.
  • Cullinan Oncology made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1974 holding.
  • Ameritas Investment Partners first reported a position in Cullinan Oncology in Q1 2021 and has held it in 21 quarters since.
  • Ameritas Investment Partners's Cullinan Oncology position peaked at $87.7K in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.